Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
Background
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Items 501–600 of 1,000
Choi, Y. J., Sáez, B., Anders, L., Hydbring, P., Stefano, J., Bacon, N. A., Cook, C., Kalaszczyńska, I., Signoretti, S., Young, R. A., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.06.015 · Cited by 33
“pRB phosphorylation causes derepression and activation of pRB-bound E2F transcription factors, which promote cell cycle progression and DNA synthesis (S phase) (Sherr and Roberts, 2004).”
BackgroundInfluentialPalombo, R., Frisone, P., Fidaleo, M., Mercatelli, N., Sette, C., & Paronetto, M. P. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2403 · Cited by 29
Management of Drug Resistance in Mantle Cell Lymphoma
Roué, G., & Sola, B. (2020) · Cancers · doi:10.3390/cancers12061565 · Cited by 31
“Associated with its specific kinases, CDK4/6, cyclin D1 phosphorylates and inhibits the retinoblastoma protein (RB1), allowing the release of transcription factors of the E2F family, the transcriptional activation of genes controlling DNA synthesis, and the G1-to-S phase progression within the cell cycle [44].”
BackgroundTherapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
Sager, R., Backe, S. J., Ahanin, E. F., Smith, G., Nsouli, I. S., Woodford, M. R., Bratslavsky, G., Bourboulia, D., & Mollapour, M. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00571-8 · Cited by 29
Arecoline augments cellular proliferation in the prostate gland of male Wistar rats
Saha, I., Chatterjee, A., Mondal, A., Br, M., & Chatterji, U. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.06.010 · Cited by 29
“Mitogenic stimuli typically trigger accumulation of D-type cyclins (cyclins D1, D2, and/or D3), which can bind and activate the early G1 kinases CDK4 or CDK6 (Sherr and Roberts, 2004).”
BackgroundCyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility
Fernández-Hernández, R., Ruiz-Miró, M., Dolcet, X., Aldea, M., & Garí, E. (2011) · Oncogene · doi:10.1038/onc.2010.577 · Cited by 34
Characterization of adipose-derived stem cells of anatomical region from mice
Luna, A. C. D. L., Madeira, M. E., Conceição, T. D. O., Moreira, J. A., Laiso, R. A. N., & Maria, D. A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-552 · Cited by 33
“In early G1-phase, cyclin-D family comes together in a holoenzyme complex with one or two catalytic subunits of cyclin-dependent kinases (CDKS), Cdk4 e Cdk6 [28].”
BackgroundYun, H. J., Hyun, S. K., Park, J. H., Kim, B. W., & Kwon, H. J. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1180-z · Cited by 29
“At the latter step of G1 phase and the early S phase, Cdk2 and cyclin E/A are transformed into a complex and activated [2].”
BackgroundNDRG2 in rat liver regeneration: Role in proliferation and apoptosis
Yang, J., Li, Y., Wu, L., Zhang, Z., Han, T.-L., Guo, H., Jiang, N., Tao, K., Ti, Z., Liu, X., et al. (2010) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00614.x · Cited by 30
Pajalunga, D., Mazzola, A., Franchitto, A., Puggioni, E. M. R., & Crescenzi, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7425-z · Cited by 32
Li, L., Wang, H., Kim, J. S., Pihan, G. A., & Boussiotis, V. A. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8738 · Cited by 30
Cannon, J. D., Cherian‐Shaw, M., Lovekamp-Swan, T., & Chaffin, C. L. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.09.015 · Cited by 33
New Approaches Towards Targeted Therapy for Childhood Neuroblastoma
Dalianis, T., Lukoseviciute, M., Holzhauser, S., & Kostopoulou, O. N. (2023) · Anticancer Research · doi:10.21873/anticanres.16570 · Cited by 33
Akiba, J., Murakami, Y., Noda, M., Watari, K., Ogasawara, S., Yoshida, T., Kawahara, A., Sanada, S., Yasumoto, M., Yamaguchi, R., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.034 · Cited by 28
Schisandra sphenanthera Extract Facilitates Liver Regeneration after Partial Hepatectomy in Mice
Li, X., Fan, X., Li, D., Zeng, X., Zeng, H., Wang, Y.-T., Zhou, Y., Chen, Y., Huang, M., & Bi, H. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068288 · Cited by 30
“In the next phase, hepatic cells undergo the G 1 to S transition, and p-Rb is activated by elevated levels of active cyclin D1/CDK4, and S phase PCNA(Sherr and Roberts, 2004). p21 and p27, known as cell cycle inhibitors, inhibit the cyclin D1-CDK4 complex and binds to PCNA,causing cell cycle…”
BackgroundRheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
Gao, Y., Gao, J., Li, M., Zheng, Y., Wang, Y., Zhang, H., Wang, W., Chu, Y., Wang, X., Xu, M., et al. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0264-3 · Cited by 29
“Since cell cycle progression is controlled through various regulators, such as cyclins, cyclin-dependent kinases (CDKs) [41], and CDK inhibitors (CKIs) [42], we also examined the expression of these genes and observed that the mRNA expressions of p18, p21, p27, and p57 were increased in Rheb1 GFP cells compared with c…”
Quantitative Studies for Cell-Division Cycle Control
Arata, Y., & Takagi, H. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01022 · Cited by 29
“The exponent of the alpha curve was the same as the exponent of the beta curve, which was determined by the difference of the cell-cycle duration between sister cells (Figure 1B; Shields and Smith, 1977; Shields et al., 1978).”
MethodICP0 enables and monitors the function of D cyclins in herpes simplex virus 1 infected cells
Kalamvoki, M., & Roizman, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906905106 · Cited by 29
“The functions of D cyclins have been reviewed extensively (14, 15).”
BackgroundZheng, X., Sun, R., & Wei, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1438235 · Cited by 36
“Secondly, by inhibiting cyclin-Zheng dependent kinase 2 (Cdk2), PD-1 ampli fi es Smad3-mediated transactivation by transforming growth factor b (TGF-b ) (93, 94), promoting Foxp3 transcription (95).”
BackgroundInvestigational cell cycle inhibitors in clinical trials for bladder cancer
Yun, S. J., Moon, S., & Kim, W. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.751097 · Cited by 27
“After various stimuli that include growth-controlling signals, cells are stimulated to divide by mitogens and exit through the G1-phase of the cell cycle, which results in entry into the S-phase and G2/ M-phases [7].”
BackgroundSee, W. Z. C., Naidu, R., & Tang, K. S. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230126161524 · Cited by 30
“Cyclin D1 is a member of the cyclin protein family that positively regulates the G1/S transition – the only checkpoint in the cell cycle when cells can commit to another round of division or exit the cell cycle [129].”
BackgroundMovva, S., Matloob, S., Handorf, E. A., Choy, E., Merriam, P. A., Flieder, D. B., Cai, K. Q., Zhou, Y., Tetzlaff, E. D., Pagan, C., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2469 · Cited by 29
Bisio, A., Latorre, E., Andreotti, V., Paillerets, B. B., Harland, M., Bianchi‐Scarrà, G., Ghiorzo, P., Spitale, R. C., Provenzani, A., & Inga, A. (2015) · Oncotarget · doi:10.18632/oncotarget.5387 · Cited by 29
“CDKN2A/p16INK4a (herein indicated as p16INK4a) is a critical tumor suppressor that inhibits the cyclindependent kinases CDK4 and CDK6, thereby keeping the retinoblastoma protein (pRB) in a hypo-phosphorylated state, thus leading to G1/S checkpoint activation [25].”
miR-198 Represses the Proliferation of HaCaT Cells by Targeting Cyclin D2
Wang, J., Dan, G., Shangguan, T., Hao, H., Tang, R., Peng, K., Zhao, J., Sun, H., & Zou, Z. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817018 · Cited by 27
“D-type cyclins are known to play critical roles in cell cycle progression [11].”
BackgroundLin, J., Fang, S.-U., Su, C.-L., Hsiao, C.-J., Chang, C., Lin, Y., & Cheng, C. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.10.006 · Cited by 27
Chanal, M., Chevallier, P., Raverot, V., Fonteneau, G., Lucia, K. E., Garcia, J. L. M., Rachwan, A., Jouanneau, E., Trouillas, J., Honnorat, J., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0891 · Cited by 27
“Cyclin D-Cdk4/6 and cyclin E-Cdk2 phosphorylate Rb, which releases E2F transcription factors to drive the expression of genes pivotal for the transition to the S phase (38).”
BackgroundmiR-873 suppresses H9C2 cardiomyocyte proliferation by targeting GLI1
Zhang, J., Zhao, Y., Lv, Y., Liu, P., Ruan, J.-X., Sun, Y., Gong, T.-X., Wan, N., & Qiu, G. (2017) · Gene · doi:10.1016/j.gene.2017.05.062 · Cited by 27
Siegenthaler, J. A., & Miller, M. W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03461.x · Cited by 27
Caron, D., Savard, P. E., Doillon, C. J., Olivier, M., Shink, É., Lussier, J. G., & Faure, R. L. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.12.012 · Cited by 27
“Elements regulating the cell cycle are more redundant than previously thought [37,41].”
BackgroundLe, X., Betrosian, I., Mao, W., Murray, M. M., Lü, Z., Keyomarsi, K., Lee, M., Zhao, J., & Bast, R. C. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3007 · Cited by 27
Tyagarajan, S. K., & Frisque, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2083-2091.2006 · Cited by 27
“Cyclin-Cdk complexes phosphorylate pRb, p107, and p130, thereby causing the release of their E2F partners, which activate the expression of S-phase genes (21, 26).”
BackgroundHeme oxygenase 1 facilitates cell proliferation via the B-Raf-ERK signaling pathway in melanoma
Liu, L., Wu, Y. L., Bian, C., Nisar, M. F., Wang, M., Hu, X., Diao, Q., Nian, W., Wang, E., Xu, W., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-018-0313-3 · Cited by 26
“CDKs are protein kinases that regulate the cell cycle by binding to cyclin [31, 32].”
Recent advances in targeting protein kinases and pseudokinases in cancer biology
Riegel, K., Vijayarangakannan, P., Kechagioglou, P., Bogucka, K., & Rajalingam, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.942500 · Cited by 27
“CDK4/6 are crucial regulators of the G1/S transition, and their activity is activated by the D-type cyclins D1, D2, and D3 (cyclin D) (Morgan, 1997; Sherr and Roberts, 2004).”
BackgroundZhang, J., Zhang, D., Wu, X., Wang, Y.-Z., Gu, S., Zhu, G., Li, X., Li, Q., & Gao-lin, L. (2015) · BMC Cancer · doi:10.1186/s12885-015-1809-5 · Cited by 26
“Progression through the S-phase must be strictly controlled so that cells undergo only a single round of chromosomal DNA replication.”
BackgroundBilbao, P., & Boland, R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.05.034 · Cited by 27
Madureira, P. A., Matos, P., Soeiro, I., Dixon, L. K., Simas, J. P., & Lam, E. W. ‐. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507478200 · Cited by 26
Sacco, E., Hasan, M. M., Alberghina, L., & Vanoni, M. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.09.009 · Cited by 28
Kolettas, E., Thomas, C. G., Leneti, E., Skoufos, I., Batsi, C., Sisoula, C., Manos, G., & Evangelou, A. M. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9064-8 · Cited by 26
Kim, H., Jo, C., Jang, B. G., Oh, U., & Jo, S. A. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.09.004 · Cited by 29
Wierød, L., Rosseland, C. M., Lindeman, B., Oksvold, M. P., Grøsvik, H., Skarpen, E., & Huitfeldt, H. S. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00451.x · Cited by 28
“2004; Sherr & Roberts 2004; Su & Stumpff 2004; Sanchez & Dynlacht 2005) has been in dispute.”
BackgroundQuantitative phosphoproteomics of transforming growth factor‐β signaling in colon cancer cells
Ali, N., & Molloy, M. P. (2011) · PROTEOMICS · doi:10.1002/pmic.201100036 · Cited by 28
“CDK2, in association with cyclin E and cyclin A is required for the progression of G1–S phase of the cell cycle (reviewed in [42]), whereas CDK1 associates with cyclin A and cyclin B for G2–M progression and the completion of mitosis, respectively [43, 44].”
BackgroundLi, Q., Zhou, L., Wang, M., Wang, N., Li, C., Wang, J., & Qi, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.044 · Cited by 26
RetractedWu, H., Li, L., Ai, Z., Yin, J., & Chen, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.9903 · Cited by 28
“Pristimerin exhibited potent anti-proliferative and apoptosis-inducing effects on the OSCC cell lines CAL-27 and SCC-25.”
Divide or Commit – Revisiting the Role of Cell Cycle Regulators in Adult Hippocampal Neurogenesis
Urbach, A., & Witte, O. W. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00055 · Cited by 30
Vu, T., Straube, J., Porter, A. H., Bywater, M. J., Song, A., Ling, V., Cooper, L. T., Pali, G., Bruedigam, C., Jacquelin, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16840-2 · Cited by 30
A distinct type of cyclin D, CYCD4;2, involved in the activation of cell division in Arabidopsis
Kono, A., Ohno, R., Umeda‐Hara, C., Uchimiya, H., & Umeda, M. (2006) · Plant Cell Reports · doi:10.1007/s00299-005-0075-4 · Cited by 26
“Mitogen-induced signals stimulate the cyclin D–CDK complexes at multiple levels, including gene transcription, translation, protein stability and assembly and import of the complex into the nucleus (Sherr and Roberts 2004).”
RETRACTED ARTICLE: Cyclin D3 predicts disease-free survival in breast cancer
Chi, Y., Huang, S., Liu, M., Guo, L., Shen, X., & Wu, J. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0245-6 · Cited by 26
“Discussion D-type cyclins (D1, D2, and D3) bind cyclin dependent kinases 4 and 6 (CDK4/6), and the activity of cyclin D/ CDK complexes promotes entry into cell cycle [10, 11].”
RetractedRole of DMP1 and its future in lung cancer diagnostics
Sugiyama, T., Frazier, D. P., Taneja, P., Morgan, R. L., Willingham, M. C., & Inoue, K. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.4.435 · Cited by 28
Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3
Young, C. D., Nolte, E., Lewis, A. S., Serkova, N. J., & Anderson, S. M. (2008) · Breast Cancer Research · doi:10.1186/bcr2132 · Cited by 29
DNA damage response in proliferating Müller glia in the mammalian retina
Nomura-Komoike, K., Saitoh, F., Komoike, Y., & Fujieda, H. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-18101 · Cited by 25
Runx3 plays a critical role in restriction-point and defense against cellular transformation
Chi, X.-Z., Lee, J., Lee, Y.-S., Park, I. Y., Ito, Y., & Bae, S.-C. (2017) · Oncogene · doi:10.1038/onc.2017.290 · Cited by 26
Tu, J., Zhao, Z., Xu, M., Chen, M., Weng, Q., Wang, J., & Ji, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27737 · Cited by 25
RetractedNovotný, J., Bandúrová, V., Strnad, H., Chovanec, M., Hradilová, M., Šáchová, J., Šteffl, M., Grušanović, J., Kodet, R., Pačes, V., et al. (2020) · Cancers · doi:10.3390/cancers12040792 · Cited by 26
“These studies suggested that D-cyclins can compensate for the loss of another family member [45].”
BackgroundAlam, S., Zunic, A., Venkat, S., Feigin, M. E., & Atanassov, B. S. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0259 · Cited by 25
Many Functions of Telomerase Components: Certainties, Doubts, and Inconsistencies
Udroiu, I., Marinaccio, J., & Sgura, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315189 · Cited by 26
“D-type cyclins (D1, D2 and D3), which are regulators of G1 phase progression and are part of the pRB/E2F pathway [91], have been showed to be regulated by TERT.”
BackgroundExpression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer
Myklebust, M. P., Li, Z., Tran, T., Rui, H., Knudsen, E. S., Elsaleh, H., Fluge, Ø., Vonen, B., Myrvold, H. E., Leh, S. M., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.463 · Cited by 26
“Cyclin D and cdk4/6 are important regulators of DNA replication and cell division (Sherr and Roberts, 2004; Besson et al, 2008).”
BackgroundZiegeler, G., Ming, J., Koseki, J. C., Sevinc, S., Chen, T., Ergün, S., Qin, X., & Aktas, B. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.113365 · Cited by 27
Liu, Q. Y., Wu, Z. L., Lv, W. J., Yan, Y. C., & Li, Y. P. (2007) · Cell Research · doi:10.1038/sj.cr.7310144 · Cited by 26
Ethanol induces cytostasis of cortical basal progenitors
Riar, A. K., Narasimhan, M., Rathinam, M. L., Henderson, G. I., & Mahimainathan, L. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0225-8 · Cited by 25
“Cyclin Ds are the key regulators that drive G1-S phase transition by interacting with CDK2 and phosphorylating Rb [60].”
BackgroundImportance of polyamines in cell cycle kinetics as studied in a transgenic system
Nasizadeh, S., Myhre, L., Thiman, L., Alm, K., Oredsson, S., & Persson, L. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.027 · Cited by 25
Caporali, S., Alvino, E., Starace, G., Ciomei, M., Brasca, M. G., Levati, L., Garbin, A., Castiglia, D., Covaciu, C., Bonmassar, E., et al. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.009 · Cited by 28
“Cell cycle progression is tightly regulated by a family of serine/threonine kinases that form heterodimeric complexes with cyclins and operate in distinct phases of the cell cycle (reviewed in [1–4]).”
BackgroundInfluentialp65 Negatively Regulates Transcription of the Cyclin E Gene
Janbandhu, V. C., Singh, A. K., Mukherji, A., & Kumar, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058974 · Cited by 27
Hahnvajanawong, C., Ketnimit, S., Pattanapanyasat, K., Anantachoke, N., Sripa, B., Pinmai, K., Seubwai, W., & Reutrakul, V. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00118 · Cited by 25
Hussain, S., Yuvaraj, M., Thakur, N., Salam, I., Singh, N., Mir, R., Bhat, M. A., Siddiqi, M. A., Das, B. C., & Bharadwaj, M. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20732 · Cited by 25
“Cyclin D1 is a key regulatory protein at the G1-S checkpoint of the cell cycle [16–19].”
BackgroundModeling medulloblastoma with genetically engineered mice
Fults, D. W. (2005) · Neurosurgical FOCUS · doi:10.3171/foc.2005.19.5.8 · Cited by 28
Ng, V. Y., Morisseau, C. H. P., Falck, J. R., Hammock, B. D., & Kroetz, D. L. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242013.29441.81 · Cited by 29
Hagiwara, H., Sato, H., Ohde, Y., Takano, Y., Seki, T., Ariga, T., Hokaiwado, N., Asamoto, M., Shirai, T., Nagashima, Y., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.17 · Cited by 26
“As p16INK4a prevents the entry of cells into S phase in the cell cycle by antagonizing the activity of cyclin D-dependent kinases (Sherr and Roberts, 2004), the expression of p16INK4 may contribute to some 5-aza-CdR-dependent suppressive effects on the development of Caki-1 tumours in nude mice.”
BackgroundBäumer, N., Tickenbrock, L., Tschanter, P., Isbell, L. K., Diederichs, S., Bäumer, S., Skryabin, B. V., Zhang, F., Singh, S. A., Köhler, G., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203471 · Cited by 25
Menon, V., Peterson, E. J., Valerie, K. C., Farrell, N. P., & Povirk, L. F. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.012 · Cited by 24
“The interaction of CDKs with their corresponding cyclins mediates the normal cell cycle progression from G1 to S, S to G2, and G2 to M phases [31].”
BackgroundCalvo, N., Martín, M. J., de Boland, A. R., & Gentili, C. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2013-0106 · Cited by 24
“It has been well documented that cell cycle is primarily regulated by complexes containing CDKs and cyclins, including cyclin D-CDK4/ CDK6 and cyclin E-CDK2 (Sherr and Roberts 2004), which are critical for its progression (van den Heuvel and Harlow 1993).”
BackgroundIshino, Y., Hayashi, Y., Naruse, M., Tomita, K., Sanbo, M., Fuchigami, T., Fujiki, R., Hirose, K., Toyooka, Y., Fujimori, T., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3832-13.2014 · Cited by 27
“Because Cip/Kip-type CDK inhibitors are known to target Cdk2 and suppress the G1-to-S-phase transition (Sherr and Roberts, 2004), we examined the expression of Cdk2 and found that it was downregulated after Bre1a knockdown (F(3,16) 3.”
BackgroundInfluentialKalamvoki, M., & Roizman, B. (2010) · Journal of Virology · doi:10.1128/jvi.01050-10 · Cited by 36
G1 Phase: Components, Conundrums, Context
Moeller, S. J., & Sheaff, R. J. (2006) · Springer eBooks · doi:10.1007/b136683 · Cited by 28
Yang, V. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00008-6 · Cited by 27
Irreversible Transitions, Bistability and Checkpoint Controls in the Eukaryotic Cell Cycle
Tyson, J. J., & Novák, B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385944-0.00014-9 · Cited by 25
“In particular, the Start transition in budding yeast is quite analogous to the ‘restriction point’ (RP) in the mammalian cell cycle [70].”
BackgroundMahajan, A., Guo, Y., Yuan, C., Weghorst, C. M., Tsai, M.-D., & Li, J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.08.038 · Cited by 18
Mouse Models of Cell Cycle Regulators: New Paradigms
Aleem, E. A., & Kaldis, P. (2006) · Springer eBooks · doi:10.1007/400_023 · Cited by 25
Albero, M. P., Vaquer, J. M., Andreu, E. J., Villanueva, J. J., Franch, L., Ivorra, C., Poch, E., Agirre, X., Prósper, F., & Pérez‐Roger, I. (2010) · Oncogene · doi:10.1038/onc.2010.81 · Cited by 23
Stem cell decision making and critical-like exploratory networks
Halley, J. D., Burden, F. R., & Winkler, D. A. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.03.001 · Cited by 27
“Similarly, as hair follicle stem cells become activated during hair growth, NFATc1, which represses the cyclin dependent kinase 4 gene encoding CDK4, is downregulated (Sherr and Roberts, 2004; Horsley et al., 2008).”
BackgroundSuzuki, R., Fukui, T., Kishimoto, M., Miyamoto, S., Takahashi, Y., Takeo, M., Mitsuyama, T., Sakaguchi, Y., Uchida, K., Nishio, A., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv073 · Cited by 24
Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells
Wu, Y., Guo, X., Brandt, Y. I., Hathaway, H. J., & Hartley, R. S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1013-x · Cited by 27
“Cyclin E1, as regulator of re-entry into G1 from G0 [3] and the G1 to S phase (DNA synthesis) transition [4], has been identified as a prognostic factor in Electronic supplementary material The online version of this article (doi:10.”
BackgroundJiang, W., Jiang, C., Pei, H., Wang, L., Zhang, J., Hu, H., & Lü, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0908 · Cited by 24
Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators
Herrera‐Moreno, J. F., Medina‐Díaz, I. M., Bernal-Hernández, Y. Y., Ramos, K. S., Alvarado-Cruz, I., Quintanilla‐Vega, B., González-Arias, C. A., Barrón-Vivanco, B. S., & Rojas‐García, A. E. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-04658-5 · Cited by 23
GA‐binding protein regulates KIS gene expression, cell migration, and cell cycle progression
Crook, M. F., Olive, M., Xue, H., Langenickel, T., Boehm, M., Leonard, W. J., & Nabel, E. G. (2007) · The FASEB Journal · doi:10.1096/fj.07-8573com · Cited by 23
“The protein p27 is a member of the Cip/Kip family of cyclin-dependent kinase inhibitors (CKIs) (1) and plays a critical role in regulating the progression through the G1/S phases of the cell cycle (1).”
BackgroundAusserlechner, M. J., Obexer, P., Deutschmann, A. J., Geiger, K., & Kofler, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0500 · Cited by 27
Li, Y., Barbash, O., & Diehl, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00011-1 · Cited by 30
Zschemisch, N., Liedtke, C., Dierssen, U., Nevzorova, Y. A., Wüstefeld, T., Borlak, J. T., Manns, M. P., & Trautwein, C. (2006) · Hepatology · doi:10.1002/hep.21224 · Cited by 23
ERK1/2 and p38 cooperate to delay progression through G1 by promoting cyclin D1 protein turnover
Densham, R. M., Todd, D. E., Balmanno, K., & Cook, S. J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.07.005 · Cited by 22
Li, J., Zeng, T., Tang, S., Zhong, M., Huang, Q., Li, X., & He, X. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02594-w · Cited by 22
“CyclinD-CDK4 complexes can be regulated p21 [24], and D-type cyclins and CDK4 also have a typical function related to cell proliferation [25].”
BackgroundRoles of ER β and GPR30 in Proliferative Response of Human Bladder Cancer Cell to Estrogen
Huang, W., Chen, Y., Liu, Y., Zhang, Q., Yu, Z., Mou, L., Wu, H., Zhao, L., Long, T., Qin, D., et al. (2015) · BioMed Research International · doi:10.1155/2015/251780 · Cited by 22
Kim, J., LEE, J.-I., Jin, D.-H., Lee, W. J., Park, G. B., Kim, S., Kim, Y. S., Wu, T. ‐., Hur, D. Y., & Kim, D. (2014) · Oncology Reports · doi:10.3892/or.2014.3082 · Cited by 22
Eto, I. (2010) · Cancer Cell International · doi:10.1186/1475-2867-10-3 · Cited by 23
“Two families of CDIs regulate the cyclin/CDK complexes [1-6], namely (a) the inhibitor of CDK4 (INK4) family members and (b) members of kinase inhibitor protein family, p27(Kip1), p57(Kip2) and p21(Cip1Waf1), which bind and inhibit cyclin E and cyclin A-bound CDK2.”
BackgroundPrével, C., Kurzawa, L., Van, T. N. N., & Morris, M. C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.003 · Cited by 23
Liu, H., Wei, J., Sang, N., Zhong, X. Z., Zhou, X., Yang, X., Zhang, J., Zuo, Z., Zhou, Y., Yang, S., et al. (2021) · Medical Oncology · doi:10.1007/s12032-021-01572-0 · Cited by 22
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice
Pieters, T., T’Sas, S., Vanhee, S., Almeida, A., Driege, Y., Roels, J., Loocke, W. V., Daneels, W., Baens, M., Marchand, A., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202280 · Cited by 23
“Gene function studies have demonstrated that D-type cyclins have partially overlapping and redundant roles in cell cycle control (Musgrove et al., 2011; Sherr and Roberts, 2004).”
BackgroundRestriction beyond the restriction point: mitogen requirement for G2 passage.
Foijer, F., & Riele, H. T. (2006) · Cell Division · doi:10.1186/1747-1028-1-8 · Cited by 25
“Pardee found that cells that have passed the G1 restriction point can progress through S-phase and complete mitosis independently of mitogens[3].”
BackgroundKundumani‐Sridharan, V., Wang, D., Karpurapu, M., Liu, Z., Zhang, C., Dronadula, N., & Rao, G. N. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061258 · Cited by 22
Maid (GCIP) is involved in cell cycle control of hepatocytes
Sonnenberg-Riethmacher, E., Wüstefeld, T., Miehe, M., Trautwein, C., & Riethmacher, D. (2007) · Hepatology · doi:10.1002/hep.21461 · Cited by 23
Liu, X., Du, L., & Feng, R. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt042 · Cited by 22
Ho, C. N. Q., Tran, M. T., Chung, Đ. C., Sơn, H. N., Tran, D. H., & Long, L. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094550 · Cited by 21
“Cell proliferation requires an increase in cell division, which is controlled by cell cycle regulators such as cyclins and Cdks [31].”
Background
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.